Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Andreas Scorilas
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Physiology
Disorders
Procedures
Concepts & Ideas
Anatomy
Sign-in to see full Profile
Network (preview)
77
Diamandis, Eleftherios
33
Yousef, George
31
Talieri, Maroulio
20
Katsaros, Dionyssios
18
Thomadaki, Hellinida
16
Soosaipillai, Antoninus
13
Fracchioli, Stefano
13
Ardavanis, Alexandros
12
Massobrio, Marco
12
Jung, Klaus
10
Magklara, Angeliki
9
Borgoño, Carla
9
Yotis, Julia
8
Trangas, Theoni
7
Schmitt, Manfred
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Andreas Scorilas (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Psyrri Amanda; Papageorgiou Sotirios; Liakata Elisavet; Scorilas Andreas; Rontogianni Dimitra; Kontos Christos K; Argyriou Pinelopi; Pectasides Dimitrios; Harhalakis Nikolaos; Pappa Vassiliki; Kolialexi Aggeliki; Economopoulou Christina; Kontsioti Frida; Maratou Eirini; Dimitriadis George; Economopoulou Panagiota; Economopoulos Theofanis
Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5724-32.
-
2009: Emami Nashmil; Scorilas Andreas; Soosaipillai Antoninus; Earle Tammy; Mullen Brendan; Diamandis Eleftherios P
Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility.
Biological chemistry 2009;390(9):921-9.
-
2009: Thomadaki Hellinida; Floros Konstantinos V; Scorilas Andreas
Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
Annals of the New York Academy of Sciences 2009;1171():276-83.
-
2009: Siu K W Michael; DeSouza Leroi V; Scorilas Andreas; Romaschin Alexander D; Honey R John; Stewart Robert; Pace Kenneth; Youssef Youssef; Chow Tsz-fung F; Yousef George M
Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Journal of proteome research 2009;8(8):3797-807.
-
2009: Theophanous Elena; Petraki Constantina; Scorilas Andreas; Komborozos Vassilios; Veloudis George; Varga Jozsef L; Zarandi Marta; Schally Andrew V; Koutsilieris Michael
The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer.
Molecular medicine (Cambridge, Mass.) 2009;15(7-8):242-7.
-
2009: Talieri M; Li L; Zheng Y; Alexopoulou D K; Soosaipillai A; Scorilas A; Xynopoulos D; Diamandis E P
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.
British journal of cancer 2009;100(10):1659-65.
-
2009: Korbakis Dimitrios; Gregorakis Alkiviades K; Scorilas Andreas
Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.
Clinical chemistry 2009;55(5):904-13.
-
2009: Papadokostopoulou Alexandra; Mathioudaki Konstantina; Scorilas Andreas; Xynopoulos Dimitrios; Ardavanis Alexandros; Kouroumalis Elias; Talieri Maroulio
Colon cancer and protein arginine methyltransferase 1 gene expression.
Anticancer research 2009;29(4):1361-6.
-
2009: Talieri Maroulio; Mathioudaki Konstantina; Prezas Panagiotis; Alexopoulou Dimitra K; Diamandis Eleftherios P; Xynopoulos Dimitris; Ardavanis Alexandros; Arnogiannaki Niki; Scorilas Andreas
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Thrombosis and haemostasis 2009;101(4):741-7.
-
2009: Kountourakis Panteleimon; Psyrri Amanda; Scorilas Andreas; Markakis Sonia; Kowalski Diane; Camp Robert L; Diamandis Eleftherios P; Dimopoulos Meletios A
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Thrombosis and haemostasis 2009;101(3):541-6.
-
2009: Devetzi Marina; Scorilas Andreas; Tsiambas Evangelos; Sameni Mansoureh; Fotiou Stelios; Sloane Bonnie F; Talieri Maroulio
Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
Gynecologic oncology 2009;112(3):531-6.
-
2009: Papachristopoulou Georgia; Avgeris Margaritis; Scorilas Andreas
Expression analysis and study of KLK4 in benign and malignant breast tumours.
Thrombosis and haemostasis 2009;101(2):381-7.
-
2009: Thomadaki Hellinida; Mavridis Konstantinos; Talieri Maroulio; Scorilas Andreas
Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
Thrombosis and haemostasis 2009;101(2):373-80.
-
2009: Korbakis Dimitrios; Scorilas Andreas
Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(2):100-7.
-
2008: Kountourakis Panteleimon; Psyrri Amanda; Scorilas Andreas; Camp Robert; Markakis Sonia; Kowalski Diane; Diamandis Eleftherios P; Dimopoulos Meletios A
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
Cancer science 2008;99(11):2224-9.
-
2008: Thomadaki Hellinida; Scorilas Andreas
Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
Biological chemistry 2008;389(11):1427-34.
-
2008: Avgeris Margaritis; Koutalellis Georgios; Fragoulis Emmanuel G; Scorilas Andreas
Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
Clinical biochemistry 2008;41(14-15):1140-9.
-
2008: Garoufali A; Kyriakou F; Kountourakis P; Yioti I; Malliou S; Nikaki A; Kardara E; Frangos I; Koumna S; Baziotis N; Scorilas A; Ardavanis A
Extracellular domain of HER2: a useful marker for the initial workup and follow-up of HER2-positive breast cancer.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2008;13(3):409-13.
-
2008: Ardavanis Alexandros; Koumna Stella; Fragos Ioannis; Malliou Savvoula; Kyriakou Flora; Mantzaris Ioannis; Scorilas Andreas; Rigatos Gerassimos
Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity.
Anticancer research 2008;28(4C):2409-15.
-
2008: Thomadaki Hellinida; Karaliota Alexandra; Litos Charalambos; Scorilas Andreas
Enhanced concentration-dependent cytotoxic effect of the dinuclear copper(II) complex of L-carnitine [Cu2(L-carnitine)2Cl2(H2O)2]Cl2, compared to L-carnitine or copper chloride dihydrate, in human leukemic cell lines.
Journal of medicinal chemistry 2008;51(13):3713-9.
-
2008: Pampalakis Georgios; Scorilas Andreas; Sotiropoulou Georgia
Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer.
Clinical biochemistry 2008;41(7-8):591-7.
-
2008: Gregorakis Alkibiades K; Stefanakis Stefanos; Malovrouvas Dimitrios; Petraki Konstantina; Gourgiotis Dimitrios; Scorilas Andreas
Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.
The Prostate 2008;68(7):759-65.
-
2008: Ardavanis Alexandros; Kountourakis Panteleimon; Kyriakou Flora; Malliou Savoula; Mantzaris Ioannis; Garoufali Anastasia; Yiotis Ioulia; Scorilas Andreas; Baziotis Nikolaos; Rigatos Gerasimos
Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer.
The oncologist 2008;13(4):361-9.
-
2008: Thomadaki Hellinida; Tsiapalis Chris Milto; Scorilas Andreas
The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines.
Cancer chemotherapy and pharmacology 2008;61(4):703-11.
-
2008: Thomadaki Hellinida; Scorilas Andreas; Tsiapalis Chris Milto; Havredaki Maria
The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner.
Cancer chemotherapy and pharmacology 2008;61(2):251-65.
-
2008: Thomadaki Hellinida; Scorilas Andreas
Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs.
Connective tissue research 2008;49(3):261-4.
-
2007: Zheng Yingye; Katsaros Dionyssios; Shan Shannon J C; de la Longrais Irene Rigault; Porpiglia Mauro; Scorilas Andreas; Kim Nam W; Wolfert Robert L; Simon Iris; Li Lin; Feng Ziding; Diamandis Eleftherios P
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6984-92.
-
2007: Revelos Kyriakos; Petraki Constantina; Scorilas Andreas; Stefanakis Stefanos; Malovrouvas Dimitrios; Alevizopoulos Nektarios; Kanellis George; Halapas Antonis; Koutsilieris Michael
Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
Anticancer research 2007;27(5B):3651-60.
-
2007: Katsarou Maria E; Thomadaki Hellinida; Katsaros Nikos; Scorilas Andreas
Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells.
Biological chemistry 2007;388(8):773-8.
-
2007: Simon Iris; Katsaros Dionyssios; Rigault de la Longrais Irene; Massobrio Marco; Scorilas Andreas; Kim Nam W; Sarno Mark J; Wolfert Robert L; Diamandis Eleftherios P
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Gynecologic oncology 2007;106(2):334-41.
-
2007: Dorn Julia; Schmitt Manfred; Kates Ronald; Schmalfeldt Barbara; Kiechle Marion; Scorilas Andreas; Diamandis Eleftherios P; Harbeck Nadia
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1742-8.
-
2007: Thomadaki Hellinida; Karaliota Alexandra; Litos Charalambos; Scorilas Andreas
Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.
Journal of medicinal chemistry 2007;50(6):1316-21.
-
2007: Thomadaki Hellinida; Talieri Maroulio; Scorilas Andreas
Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
Cancer letters 2007;247(1):48-55.
-
2007: Thomadaki Hellinida; Scorilas Andreas
Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Annals of the New York Academy of Sciences 2007;1095():35-44.
-
2007: Shan S J C; Scorilas A; Katsaros D; Diamandis E P
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.
British journal of cancer 2007;96(2):362-72.
-
2007: Efthimiadou Eleni K; Thomadaki Hellinida; Sanakis Yiannis; Raptopoulou Catherine P; Katsaros Nikos; Scorilas Andreas; Karaliota Alexandra; Psomas George
Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2'-bipyridine.
Journal of inorganic biochemistry 2007;101(1):64-73.
-
2006: Floros Kostas V; Thomadaki Hellinida; Florou Dimitra; Talieri Maroulio; Scorilas Andreas
Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
Annals of the New York Academy of Sciences 2006;1090():89-97.
-
2006: Floros Kostas V; Talieri Maroulio; Scorilas Andreas
Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.
Biological chemistry 2006;387(12):1629-33.
-
2006: Leoutsakou Theoni; Talieri Maroulio; Scorilas Andreas
Prognostic significance of the expression of SR-A1, encoding a novel SR-related CTD-associated factor, in breast cancer.
Biological chemistry 2006;387(12):1613-8.
-
2006: Prezas Panagiotis; Scorilas Andreas; Yfanti Christina; Viktorov Petar; Agnanti Niki; Diamandis Eleftherios; Talieri Maroulio
The role of human tissue kallikreins 7 and 8 in intracranial malignancies.
Biological chemistry 2006;387(12):1607-12.
-
2006: Shan Shannon J C; Scorilas Andreas; Katsaros Dionyssios; Rigault de la Longrais Irene; Massobrio Marco; Diamandis Eleftherios P
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
Clinical chemistry 2006;52(10):1879-86.
-
2006: Thomadaki Hellinida; Talieri Maroulio; Scorilas Andreas
Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS.
Biological chemistry 2006;387(8):1081-6.
-
2006: Slagter Margrita H; Scorilas Andreas; Gooren Louis J G; de Ronde Willem; Soosaipillai Antoninus; Giltay Erik J; Paliouras Miltiadis; Diamandis Eleftherios P
Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals.
Clinical chemistry 2006;52(8):1546-51.
-
2006: Slagter Margrita H; Gooren Louis J G; Scorilas Andreas; Petraki Constantina D; Diamandis Eleftherios P
Effects of long-term androgen administration on breast tissue of female-to-male transsexuals.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2006;54(8):905-10.
-
2006: Slagter Margrita H; Gooren Louis J G; de Ronde Willem; Soosaipillai Antoninus; Scorilas Andreas; Giltay Erik J; Paliouras Miltiadis; Diamandis Eleftherios P
Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens.
Clinical chemistry 2006;52(7):1356-65.
-
2006: Scorilas Andreas; Gregorakis Alkiviades K
mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy.
Biological chemistry 2006;387(6):789-93.
-
2006: Lundwall Ake; Band Vimla; Blaber Michael; Clements Judith A; Courty Yves; Diamandis Eleftherios P; Fritz Hans; Lilja Hans; Malm Johan; Maltais Lois J; Olsson A Yvonne; Petraki Constantina; Scorilas Andreas; Sotiropoulou Georgia; Stenman Ulf-Håkan; Stephan Carsten; Talieri Maroulio; Yousef George M
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.
Biological chemistry 2006;387(6):637-41.
-
2006: Ardavanis Alexandros; Scorilas Andreas; Tryfonopoulos Dimitrios; Orphanos Georgios; Missitzis Ioannis; Karamouzis Michael; Chrysochoou Minas; Sotiropoulou Anastasia; Arnogiannaki Niki; Ioannidis Georgios; Pissakas Georgios; Rigatos Gerassimas
Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
The oncologist 2006;11(6):563-73.
-
2006: Leoutsakou Theoni; Talieri Maroulio; Scorilas Andreas
Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer.
Biochemical and biophysical research communications 2006;344(2):667-74.
-
2006: Borgoño Carla A; Kishi Tadaaki; Scorilas Andreas; Harbeck Nadia; Dorn Julia; Schmalfeldt Barbara; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1487-93.
-
2006: Thomadaki Hellinida; Scorilas Andreas
BCL2 family of apoptosis-related genes: functions and clinical implications in cancer.
Critical reviews in clinical laboratory sciences 2006;43(1):1-67.
-
2006: Oikonomopoulou Katerina; Scorilas Andreas; Michael Iacovos P; Grass Linda; Soosaipillai Antoninus; Rosen Barry; Murphy Joan; Diamandis Eleftherios P
Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(2):104-14.
-
2005: Ardavanis Alexandros; Tryfonopoulos Dimitrios; Orfanos G; Karamouzis Mihalis; Scorilas Andreas; Alexopoulos A; Rigatos Gerassimos
Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series.
Onkologie 2005;28(11):558-64.
-
2005: Revelos Kyriakos; Petraki Constantina; Gregorakis Alkiviadis; Scorilas Andreas; Papanastasiou Panagiotis; Tenta Roxane; Koutsilieris Michael
p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
In vivo (Athens, Greece) 2005;19(5):911-20.
-
2005: Katsarou Maria E; Papakyriakou Athanasios; Katsaros Nikos; Scorilas Andreas
Expression of the C-terminal domain of novel human SR-A1 protein: interaction with the CTD domain of RNA polymerase II.
Biochemical and biophysical research communications 2005;334(1):61-8.
-
2005: Revelos Kyriakos; Petraki Constantina; Gregorakis Alkiviadis; Scorilas Andreas; Papanastasiou Panagiotis; Koutsilieris Michael
Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy.
Anticancer research 2005;25(4):3123-33.
-
2005: Yannopoulos A; Dimitriadis E; Scorilas A; Trangas T; Markakis E; Talieri M
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.
British journal of cancer 2005;93(1):152-8.
-
2005: Gregorakis Alkiviades K; Malovrouvas Dimitrios; Stefanakis Stefanos; Petraki Konstantina; Scorilas Andreas
Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):196-201.
-
2005: Scorilas Andreas; Agiamarnioti Kalomoira; Papadopoulos Kyriakos
Novel biotinylated acridinium derivatives: new reagents for fluorescence immunoassays and proteomics.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):159-67.
-
2005: Stavropoulou Panagiota; Gregorakis Alkiviades K; Plebani Mario; Scorilas Andreas
Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):190-5.
-
2005: Thomadaki Hellinida; Tsiapalis Chris M; Scorilas Andreas
Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction.
Biological chemistry 2005;386(5):471-80.
-
2005: Yousef George M; Obiezu Christina V; Luo Liu-Ying; Magklara Angeliki; Borgoño Carla A; Kishi Tadaaki; Memari Nader; Michael lacovos P; Sidiropoulos Michael; Kurlender Lisa; Economopolou Katerina; Kapadia Carl; Komatsu Nahoko; Petraki Constantina; Elliott Marc; Scorilas Andreas; Katsaros Dionyssios; Levesque Michael A; Diamandis Eleftherios P
Human tissue kallikreins: from gene structure to function and clinical applications.
Advances in clinical chemistry 2005;39():11-79.
-
2004: Floros Kostas V; Thomadaki Hellinida; Katsaros Nikos; Talieri Maroulio; Scorilas Andreas
mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin.
Biological chemistry 2004;385(11):1099-103.
-
2004: Mathioudaki Konstantina; Leotsakou Theoni; Papadokostopoulou Alexandra; Paraskevas Emmanouil; Ardavanis Alexandros; Talieri Maroulio; Scorilas Andreas
SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression.
Biological chemistry 2004;385(9):785-90.
-
2004: Mathioudaki Konstantina; Scorilas Andreas; Papadokostopoulou Alexandra; Xynopoulos Dimitrios; Arnogianaki Niki; Agnanti Niki; Talieri Maroulio
Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
Biological chemistry 2004;385(9):779-83.
-
2004: Diamandis Eleftherios P; Borgoño Carla A; Scorilas Andreas; Harbeck Nadia; Dorn Julia; Schmitt Manfred
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients.
Clinical biochemistry 2004;37(9):823-9.
-
2004: Talieri Maroulio; Papadopoulou Sofia; Scorilas Andreas; Xynopoulos Dimitrios; Arnogianaki Niki; Plataniotis George; Yotis Julia; Agnanti Niki
Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Cancer letters 2004;205(1):97-106.
-
2004: Diamandis Eleftherios P; Scorilas Andreas; Kishi Tadaaki; Blennow Kaj; Luo Liu-Ying; Soosaipillai Antoninus; Rademaker Alfred W; Sjogren Magnus
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Clinical biochemistry 2004;37(3):230-7.
-
2004: Scorilas Andreas; Borgoño Carla A; Harbeck Nadia; Dorn Julia; Schmalfeldt Barbara; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):678-85.
-
2004: Talieri Maroulio; Diamandis Eleftherios P; Gourgiotis Dimitrios; Mathioudaki Kostandina; Scorilas Andreas
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma.
Thrombosis and haemostasis 2004;91(1):180-6.
-
2004: Stephan Carsten; Yousef George M; Scorilas Andreas; Jung Klaus; Jung Monika; Kristiansen Glen; Hauptmann Steffen; Kishi Tadaaki; Nakamura Terukazu; Loening Stefan A; Diamandis Eleftherios P
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
The Journal of urology 2004;171(1):187-91.
-
2003: Floros Kostas V; Thomadaki Hellinida; Lallas George; Katsaros Nikos; Talieri Maroulio; Scorilas Andreas
Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12.
Annals of the New York Academy of Sciences 2003;1010():153-8.
-
2003: Diamandis Eleftherios P; Borgoño Carla A; Scorilas Andreas; Yousef George M; Harbeck Nadia; Dorn Julia; Schmalfeldt Barbara; Schmitt Manfred
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(6):299-309.
-
2003: Nakamura Terukazu; Scorilas Andreas; Stephan Carsten; Jung Klaus; Soosaipillai Antoninus R; Diamandis Eleftherios P
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia.
Cancer research 2003;63(19):6543-6.
-
2003: Yousef George M; Stephan Carsten; Scorilas Andreas; Ellatif Mohamed Abd; Jung Klaus; Kristiansen Glen; Jung Monika; Polymeris Mary-Ellen; Diamandis Eleftherios P
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
The Prostate 2003;56(4):287-92.
-
2003: Borgoño Carla A; Fracchioli Stefano; Yousef George M; Rigault de la Longrais Irene A; Luo Liu-Ying; Soosaipillai Antoninus; Puopolo Manuela; Grass Linda; Scorilas Andreas; Diamandis Eleftherios P; Katsaros Dionyssios
Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
International journal of cancer. Journal international du cancer 2003;106(4):605-10.
-
2003: Yousef George M; Scorilas Andreas; Katsaros Dionyssios; Fracchioli Stefano; Iskander Lisa; Borgono Carla; Rigault de la Longrais Irene A; Puopolo Manuela; Massobrio Marco; Diamandis Eleftherios P
Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3119-26.
-
2003: Yousef George M; Polymeris Mary-Ellen; Grass Linda; Soosaipillai Antoninus; Chan Pak-Cheung; Scorilas Andreas; Borgoño Carla; Harbeck Nadia; Schmalfeldt Barbara; Dorn Julia; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Cancer research 2003;63(14):3958-65.
-
2003: Talieri Maroulio; Diamandis Eleftherios P; Katsaros Nikos; Gourgiotis Dimitrios; Scorilas Andreas
Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Thrombosis and haemostasis 2003;89(6):1081-8.
-
2003: Kishi Tadaaki; Grass Linda; Soosaipillai Antoninus; Scorilas Andreas; Harbeck Nadia; Schmalfeldt Barbara; Dorn Julia; Mysliwiec Michal; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 8, a novel biomarker for ovarian carcinoma.
Cancer research 2003;63(11):2771-4.
-
2003: Scorilas Andreas; Chiang Pui Ming; Katsaros Dionyssios; Yousef George M; Diamandis Eleftherios P
Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors.
Gene 2003;310():79-89.
-
2003: Nakamura Terukazu; Stephan Carsten; Scorilas Andreas; Yousef George M; Jung Klaus; Diamandis Eleftherios P
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues.
Urology 2003;61(5):1042-6.
-
2003: Yousef George M; Polymeris Mary-Ellen; Yacoub George M; Scorilas Andreas; Soosaipillai Antoninus; Popalis Cynthia; Fracchioli Stefano; Katsaros Dionyssios; Diamandis Eleftherios P
Parallel overexpression of seven kallikrein genes in ovarian cancer.
Cancer research 2003;63(9):2223-7.
-
2003: Nakamura T; Scorilas A; Stephan C; Yousef G M; Kristiansen G; Jung K; Diamandis E P
Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues.
British journal of cancer 2003;88(7):1101-4.
-
2003: Yousef George M; Scorilas Andreas; Nakamura Terukazu; Ellatif Mohamed Abd; Ponzone Riccardo; Biglia Nicoletta; Maggiorotto Furio; Roagna Riccardo; Sismondi Piero; Diamandis Eleftherios P
The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
Breast cancer research and treatment 2003;78(2):149-58.
-
2003: Yousef George M; Fracchioli Stefano; Scorilas Andreas; Borgoño Carla A; Iskander Lisa; Puopolo Manuela; Massobrio Marco; Diamandis Eleftherios P; Katsaros Dionyssios
Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
American journal of clinical pathology 2003;119(3):346-55.
-
2003: Diamandis Eleftherios P; Scorilas Andreas; Fracchioli Stefano; Van Gramberen Marleen; De Bruijn Henk; Henrik Alfthan; Soosaipillai Antoninus; Grass Linda; Yousef George M; Stenman Ulf-Hakan; Massobrio Marco; Van Der Zee Ate G J; Vergote Ignace; Katsaros Dionyssios
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1035-43.
-
2003: Kyriakopoulou Lianna G; Yousef George M; Scorilas Andreas; Katsaros Dionyssios; Massobrio Marco; Fracchioli Stefano; Diamandis Eleftherios P
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Clinical biochemistry 2003;36(2):135-43.
-
2003: Luo Liu-Ying; Katsaros Dionyssios; Scorilas Andreas; Fracchioli Stefano; Bellino Roberto; van Gramberen Marleen; de Bruijn Henk; Henrik Alfthan; Stenman Ulf-Hakan; Massobrio Marco; van der Zee Ate G J; Vergote Ignace; Diamandis Eleftherios P
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Cancer research 2003;63(4):807-11.
-
2003: Scorilas Andreas; Plebani Mario; Mazza Saverio; Basso Daniela; Soosaipillai Antoninus R; Katsaros Nikos; Pagano Francesco; Diamandis Eleftherios P
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
The Prostate 2003;54(3):220-9.
-
2003: Stephan Carsten; Yousef George M; Scorilas Andreas; Jung Klaus; Jung Monika; Kristiansen Glen; Hauptmann Steffen; Bharaj Bhupinder S; Nakamura Terukazu; Loening Stefan A; Diamandis Eleftherios P
Quantitative analysis of kallikrein 15 gene expression in prostate tissue.
The Journal of urology 2003;169(1):361-4.
-
2002: Yousef G M; Scorilas A; Magklara A; Memari N; Ponzone R; Sismondi P; Biglia N; Abd Ellatif M; Diamandis E P
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
British journal of cancer 2002;87(11):1294-300.
-
2002: Yousef G M; Borgoño C A; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris M-E; Roagna R; Sismondi P; Diamandis E P
Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
British journal of cancer 2002;87(11):1287-93.
-
2002: Yousef George M; Obiezu Christina V; Jung Klaus; Stephan Carsten; Scorilas Andreas; Diamandis Eleftherios P
Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues.
Urology 2002;60(4):714-8.
-
2002: Hoffman B R; Katsaros D; Scorilas A; Diamandis P; Fracchioli S; Rigault de la Longrais I A; Colgan T; Puopolo M; Giardina G; Massobrio M; Diamandis E P
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.
British journal of cancer 2002;87(7):763-71.
-
2002: Yousef George M; Scorilas Andreas; Kyriakopoulou Lianna G; Rendl Laura; Diamandis Maria; Ponzone Riccardo; Biglia Nicoletta; Giai Maurizia; Roagna Riccardo; Sismondi Piero; Diamandis Eleftherios P
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Clinical chemistry 2002;48(8):1241-50.
-
2002: Obiezu Christina V; Soosaipillai Antoninus; Jung Klaus; Stephan Carsten; Scorilas Andreas; Howarth David H C; Diamandis Eleftherios P
Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
Clinical chemistry 2002;48(8):1232-40.
-
2002: Scorilas Andreas; Fotiou Stelios; Tsiambas Evangelos; Yotis Julia; Kotsiandri Fani; Sameni Mansoureh; Sloane Bonnie F; Talieri Maroulio
Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients.
Biological chemistry 2002;383(7-8):1297-303.
-
2002: Scorilas Andreas
Polyadenylate polymerase (PAP) and 3' end pre-mRNA processing: function, assays, and association with disease.
Critical reviews in clinical laboratory sciences 2002;39(3):193-224.
-
2002: Papadopoulou S; Scorilas A; Yotis J; Arnogianaki N; Plataniotis G; Agnanti N; Talieri M
Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2002;23(3):170-8.
-
2002: Zarghooni Maryam; Soosaipillai Antoninus; Grass Linda; Scorilas Andreas; Mirazimi Nader; Diamandis Eleftherios P
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients.
Clinical biochemistry 2002;35(3):225-31.
-
2002: Scorilas Andreas; Levesque Michael A; Ashworth Linda K; Diamandis Eleftherios P
Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.
Gene 2002;289(1-2):191-9.
-
2002: Chang A; Yousef G M; Scorilas A; Grass L; Sismondi P; Ponzone R; Diamandis E P
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.
British journal of cancer 2002;86(9):1457-64.
-
2002: Yousef George M; Scorilas Andreas; Chang Albert; Rendl Laura; Diamandis Maria; Jung Klaus; Diamandis Eleftherios P
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
The Prostate 2002;51(2):126-32.
-
2001: Papadopoulou S; Scorilas A; Arnogianaki N; Papapanayiotou B; Tzimogiani A; Agnantis N; Talieri M
Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(6):383-9.
-
2001: Yousef G M; Kyriakopoulou L G; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick W J; Richiardi G; Massobrio M; Diamandis E P; Katsaros D
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Cancer research 2001;61(21):7811-8.
-
2001: Obiezu C V; Scorilas A; Katsaros D; Massobrio M; Yousef G M; Fracchioli S; Rigault de la Longrais I A; Arisio R; Diamandis E P
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2380-6.
-
2001: Luo L Y; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais I A; Howarth D J; Diamandis E P
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2372-9.
-
2001: Scorilas A; Kyriakopoulou L; Katsaros D; Diamandis E P
Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
British journal of cancer 2001;85(2):190-8.
-
2001: Scorilas A; Yousef G M; Jung K; Rajpert-De Meyts E; Carsten S; Diamandis E P
Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors.
Biochemical and biophysical research communications 2001;285(2):400-8.
-
2001: Scorilas A; Karameris A; Arnogiannaki N; Ardavanis A; Bassilopoulos P; Trangas T; Talieri M
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
British journal of cancer 2001;84(11):1488-96.
-
2001: Magklara A; Scorilas A; Katsaros D; Massobrio M; Yousef G M; Fracchioli S; Danese S; Diamandis E P
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):806-11.
-
2001: Obiezu C V; Scorilas A; Magklara A; Thornton M H; Wang C Y; Stanczyk F Z; Diamandis E P
Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2001;86(4):1558-61.
-
2001: Luo L Y; Bunting P; Scorilas A; Diamandis E P
Human kallikrein 10: a novel tumor marker for ovarian carcinoma?
Clinica chimica acta; international journal of clinical chemistry 2001;306(1-2):111-8.
-
2001: Scorilas A; Kyriakopoulou L; Yousef G M; Ashworth L K; Kwamie A; Diamandis E P
Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family.
Genomics 2001;72(2):217-21.
-
2001: Scorilas A; Bharaj B; Giai M; Diamandis E P
Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer.
British journal of cancer 2001;84(6):760-7.
-
2001: Kim H; Scorilas A; Katsaros D; Yousef G M; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis E P
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
British journal of cancer 2001;84(5):643-50.
-
2001: Khosravi J; Diamandi A; Mistry J; Scorilas A
Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer.
The Journal of clinical endocrinology and metabolism 2001;86(2):694-9.
-
2001: Yousef G M; Scorilas A; Jung K; Ashworth L K; Diamandis E P
Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.
The Journal of biological chemistry 2001;276(1):53-61.
-
2000: Scorilas A; Black M H; Talieri M; Diamandis E P
Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene.
Biochemical and biophysical research communications 2000;278(2):349-59.
-
2000: Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis C M; Trangas T
Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Cancer research 2000;60(19):5427-33.
-
2000: Yousef G M; Chang A; Scorilas A; Diamandis E P
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.
Biochemical and biophysical research communications 2000;276(1):125-33.
-
2000: Scorilas A; Bjartell A; Lilja H; Moller C; Diamandis E P
Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays.
Clinical chemistry 2000;46(9):1450-5.
-
2000: Magklara A; Scorilas A; Stephan C; Kristiansen G O; Hauptmann S; Jung K; Diamandis E P
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.
Urology 2000;56(3):527-32.
-
2000: Yousef G M; Scorilas A; Magklara A; Soosaipillai A; Diamandis E P
The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation.
Gene 2000;254(1-2):119-28.
-
2000: Scorilas A; Diamandis E P
Polyvinylamine-streptavidin complexes labeled with a europium chelator: a universal detection reagent for solid-phase time resolved fluorometric applications.
Clinical biochemistry 2000;33(5):345-50.
-
2000: Obiezu C V; Giltay E J; Magklara A; Scorilas A; Gooren L J; Yu H; Howarth D J; Diamandis E P
Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals.
Clinical chemistry 2000;46(6 Pt 1):859-62.
-
2000: Bharaj B; Scorilas A; Diamandis E P; Giai M; Levesque M A; Sutherland D J; Hoffman B R
Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter.
Breast cancer research and treatment 2000;61(2):111-9.
-
2000: Bharaj B; Scorilas A; Giai M; Diamandis E P
TA repeat polymorphism of the 5alpha-reductase gene and breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(4):387-93.
-
2000: Obiezu C V; Giltay E J; Magklara A; Scorilas A; Gooren L; Yu H; Diamandis E P
Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.
The Journal of urology 2000;163(3):802-5.
-
2000: Scorilas A; Yu H; Soosaipillai A R; Gregorakis A K; Diamandis E P
Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy.
Clinica chimica acta; international journal of clinical chemistry 2000;292(1-2):127-38.
-
2000: Yousef G M; Scorilas A; Diamandis E P
Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family.
Genomics 2000;63(1):88-96.
-
1999: Scorilas A; Trangas T; Yotis J; Pateras C; Talieri M
Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.
British journal of cancer 1999;81(8):1385-91.
-
1999: Magklara A; Scorilas A; Catalona W J; Diamandis E P
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Clinical chemistry 1999;45(11):1960-6.
-
1999: Magklara A; Scorilas A; López-Otín C; Vizoso F; Ruibal A; Diamandis E P
Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid.
Clinical chemistry 1999;45(10):1774-80.
-
1999: Scorilas A; Diamandis E P; Levesque M A; Papanastasiou-Diamandi A; Khosravi M J; Giai M; Ponzone R; Roagna R; Sismondi P; López-Otin C
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1778-85.
-
1999: Scorilas A; Yotis J; Pateras C; Trangas T; Talieri M
Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):815-21.
-
1998: Scorilas A; Courtis N; Yotis J; Talieri M; Michailakis M; Trangas T
Poly(A)polymerase activity levels in breast tumour cytosols.
Journal of experimental & clinical cancer research : CR 1998;17(4):511-8.
-
1998: Ardavanis A; Scorilas A; Loukeri A; Gerakini F; Pissakas G; Missitzis I; Apostolikas N; Yiotis I
Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence.
Anticancer research 1998;18(4B):2885-90.
-
1997: Ardavanis A; Gerakini F; Amanatidou A; Scorilas A; Pateras C; Garoufali A; Pissakas G; Stravolemos K; Apostolikas N; Yiotis I
Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance.
Anticancer research 1997;17(5A):3665-9.
-
1997: Ardavanis A; Scorilas A; Amanatidou A; Gerakini F; Missitzis I; Garoufali A; Pissakas G; Pateras C; Apostolikas N; Rigatos G; Yiotis I
Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer.
Anticancer research 1997;17(2B):1405-9.
-
1995: Scorilas A; Yotis J; Stravolemos K; Gouriotis D; Keramopoulos A; Ampela K; Talieri M; Trangas T
c-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients.
Anticancer research 1995;15(4):1543-7.
-
1993: Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
Anticancer research 1993;13(5C):1895-900.
Sign-in to see more
